Sign in
4

Changes in Ownership

PUMA BIOTECHNOLOGY, INC. Filed Acc 0001437749-25-000363

Chief Commercial Officer sold 9,437 shares at $3.15 ($29,743)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ludwig Jeffrey Jerome Chief Commercial Officer 2025-01-02 Sale 10b5-1 −9,437 $3.15 $29,743 108,951 D
Open-market sales · 9,437 sh · avg $3.15 · $29,743
Loading xslF345X05/rdgdoc.xml…